Your browser is no longer supported. Please, upgrade your browser.
Settings
AMRN Amarin Corporation plc daily Stock Chart
AMRN [NASD]
Amarin Corporation plc
Index- P/E- EPS (ttm)-0.83 Insider Own0.60% Shs Outstand185.08M Perf Week-2.70%
Market Cap333.14M Forward P/E- EPS next Y-0.05 Insider Trans0.00% Shs Float149.51M Perf Month13.92%
Income-149.10M PEG- EPS next Q-0.11 Inst Own29.50% Short Float11.00% Perf Quarter32.35%
Sales81.80M P/S4.07 EPS this Y-154.30% Inst Trans-0.17% Short Ratio21.16 Perf Half Y-10.45%
Book/sh-0.84 P/B- EPS next Y86.80% ROA-77.80% Target Price6.50 Perf Year-5.26%
Cash/sh0.58 P/C3.11 EPS next 5Y- ROE121.70% 52W Range1.24 - 2.80 Perf YTD-4.76%
Dividend- P/FCF- EPS past 5Y19.80% ROI-94.40% 52W High-40.71% Beta1.10
Dividend %- Quick Ratio2.50 Sales past 5Y- Gross Margin65.90% 52W Low33.87% ATR0.09
Employees210 Current Ratio2.80 Sales Q/Q61.20% Oper. Margin- RSI (14)42.50 Volatility6.22% 4.77%
OptionableYes Debt/Eq- EPS Q/Q-5.60% Profit Margin- Rel Volume1.87 Prev Close1.80
ShortableYes LT Debt/Eq- EarningsMay 05 BMO Payout- Avg Volume777.26K Price1.66
Recom2.00 SMA20-7.82% SMA502.05% SMA200-10.81% Volume1,387,743 Change-7.78%
Mar-12-15Upgrade H.C. Wainwright Neutral → Buy $2.50 → $10
Apr-01-14Reiterated MKM Partners Neutral $1.50 → $2
Feb-24-14Reiterated MKM Partners Neutral $2.50 → $1.75
Jan-16-14Downgrade MKM Partners Buy → Neutral $2.50
Nov-08-13Reiterated MKM Partners Buy $5 → $2.50
Oct-30-13Initiated FBR Capital Mkt Perform $2
Oct-17-13Reiterated MKM Partners Buy $9 → $5
Oct-17-13Downgrade Canaccord Genuity Buy → Hold $10 → $3
Oct-17-13Downgrade Aegis Capital Buy → Hold
Mar-20-13Initiated Chardan Capital Markets Hold $8.50
Dec-10-12Reiterated Aegis Capital Buy $25 → $35
Dec-07-12Reiterated Aegis Capital Buy $25 → $35
Jul-12-11Initiated MKM Partners Buy $23
Apr-25-11Reiterated Wedbush Outperform $12 → $18
Apr-18-11Reiterated Canaccord Genuity Buy $11 → $18
Dec-29-10Reiterated Wedbush Outperform $7 → $10
Jul-20-10Initiated Wedbush Outperform $5
Feb-03-09Initiated Rodman & Renshaw Mkt Outperform $3.50
Nov-06-08Initiated Rodman & Renshaw Mkt Outperform $3.50
May-05-16 07:07AM  Q1 2016 Amarin Corporation PLC Earnings Release - Before Market Open CCBN -7.78%
07:02AM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
07:00AM  Amarin Reports First Quarter 2016 Financial Results and Provides Update on Operations Marketwired
May-04-16 04:05PM  Investor Calendar Invites You to the Amarin First Quarter 2016 Earnings Conference Call and Webcast Live on Thursday, May 5, 2016 Accesswire -5.26%
Apr-28-16 07:43AM  Amarin to Report First Quarter 2016 Results and Host Conference Call on May 5, 2016 Marketwired
Apr-11-16 08:40AM  3 Biotech Stocks With Scary-High Debt-to-Capital Ratios at Motley Fool
Apr-07-16 02:13PM  Penny Stocks To Watch: Thursday's List of Trending Small Cap Stocks April 7th Accesswire +5.28%
Apr-04-16 07:00AM  New Clinical and Pre-Clinical Data Presented at American College of Cardiology Meeting on the Effect of EPA Therapy in Statin-Treated Patients and on Endothelial Function in Exploratory Studies Marketwired
Mar-31-16 07:00AM  Amarin Reaches Target Enrollment in Cardiovascular Outcomes Study of Vascepa(R) in Patients With Elevated Triglycerides Despite Statin Therapy Marketwired
Mar-10-16 02:59PM  The US government just said a drugmaker could market its product for conditions it may not actually treat and it could forever change the industry -5.56%
Mar-09-16 04:03PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events
12:30PM  Court Approves Proposed Settlement Terms in Amarin First Amendment Litigation Marketwired
11:50AM  Amarin Reaches Settlement Terms With FDA
Mar-08-16 04:13PM  Amarin's Right to Promote Vascepa(R) Off-Label Affirmed Under First Amendment Litigation Settlement Terms Marketwired
Mar-02-16 01:04PM  AMARIN CORP PLC\UK Financials
Feb-26-16 01:56PM  ETFs with exposure to Amarin Corp. Plc : February 26, 2016
09:55AM  H.C. Wainwright Still Buying Amarin, Sees DMC Decision By Summer
08:46AM  Amarin Corp. Plc Earnings Analysis: 2015 By the Numbers
Feb-25-16 03:58PM  Edited Transcript of AMRN earnings conference call or presentation 25-Feb-16 1:00pm GMT
07:07AM  Q4 2015 Amarin Corporation PLC Earnings Release - Tentative - Before Market Open
07:01AM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
07:00AM  Amarin Reports Fourth Quarter and Year-End 2015 Financial Results and Provides Update on Operations Marketwired
Feb-24-16 04:05PM  Investor Calendar Invites You to the Amarin Corporation Fourth Quarter and Fiscal Year 2015 Earnings Conference Call and Webcast Live on Thursday, February 25, 2016 Accesswire
Feb-18-16 08:00AM  Amarin to Report Fourth Quarter and Full-Year 2015 Results and Host Conference Call on February 25, 2016 Marketwired
Feb-17-16 08:00AM  Request for Continued Stay in Court Proceedings Submitted in Amarin First Amendment Litigation Marketwired +5.30%
Jan-25-16 07:43AM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events
Jan-21-16 07:56AM  Amarin Appoints Craig B. Granowitz Chief Medical Officer and Names Steven Ketchum Chief Scientific Officer Marketwired
Jan-13-16 12:54PM  Manufacturing Production Remains Negative in the UK
12:02PM  3 Reasons Behind Amarin's Strong 2015 at Motley Fool
Jan-11-16 07:02AM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
07:00AM  Amarin Reports Preliminary 2015 Net Product Sales and Provides 2016 Revenue and Business Outlook Marketwired
Dec-22-15 09:47AM  Amarin Corp. Plc Earnings Analysis: Q3, 2015 By the Numbers
Dec-18-15 08:00AM  Healthcare Sector Equities under the Scanner -- Zogenix, Amarin, SciClone Pharma, and PetMed Express Accesswire
Dec-15-15 12:01AM  Drugmaker Settles Free Speech Dispute as FDA Agrees on Label at Bloomberg +5.41%
Dec-14-15 06:00AM  Amarin Added to NASDAQ Biotechnology Index Marketwired
Dec-04-15 09:00AM  Market Data on Movers and Shakers - Research on Medifast, Potbelly, Amarin and Idera Pharmaceuticals Accesswire
Dec-02-15 06:00AM  Amarin to Present at the Oppenheimer & Co. Inc. 26th Annual Healthcare Conference Marketwired
Dec-01-15 06:10AM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obl
Nov-30-15 03:25PM  How the bulls are playing Amarin
08:00AM  Chiasma Announces Addition of James R. Tobin and John F. Thero to Board of Directors GlobeNewswire
Nov-28-15 07:52AM  Is Rayonier Advanced Materials Inc (RYAM) A Good Stock To Buy? at Insider Monkey
Nov-25-15 11:12AM  What Hedge Funds Think About Terraping 3 Acquisition Corp (TRTL)? at Insider Monkey
Nov-24-15 06:00AM  Amarin to Present at the 27th Annual Piper Jaffray Healthcare Conference Marketwired
Nov-20-15 06:07AM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securi
06:00AM  Amarin Announces Agreement to Purchase $16.2 Million of Its Existing Exchangeable Notes and Pricing of $31.3 Million of New Exchangeable Notes Marketwired
Nov-19-15 09:05AM  Equity Market Movement at a Glance - Research on Amarin, Idera Pharmaceuticals, AgroFresh Solutions and American Public Education Accesswire
Nov-09-15 12:24PM  Amarin Popped Amid Press Release In Friday's After-Hours Session
11:14AM  EXCLUSIVE: Expect Amarin FAQ Shortly
08:35AM  Recent Technical Updates on Stocks from Diverse Sectors - Research on Medifast, Potbelly, AMARIN and Idera Pharmaceuticals Accesswire
08:07AM  EPA Therapy Added to Statin Therapy Showed Coronary Plaque Regression at Approximately Twice the Prevalence Compared to Statin Therapy Alone in Japanese Clinical Study Marketwired
Nov-04-15 04:57PM  Edited Transcript of AMRN earnings conference call or presentation 4-Nov-15 1:00pm GMT
07:07AM  Q3 2015 Amarin Corporation PLC Earnings Release - Before Market Open
07:01AM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
07:00AM  Amarin Reports Third Quarter 2015 Financial Results and Provides Update on Operations Marketwired
Nov-03-15 04:05PM  Amarin to Host Third Quarter 2015 Earnings Conference Call and Webcast Live on Wednesday, November 4, 2015 Accesswire
Oct-28-15 07:00AM  Amarin to Report Third Quarter 2015 Results and Host Conference Call on November 4, 2015 Marketwired +7.14%
Sep-17-15 10:59AM  Amarin Corp. Plc Earnings Q2, 2015
Sep-14-15 06:27AM  Tetraphase Executive Profits Hours Before Stock Plummets at TheStreet
Sep-08-15 06:04PM  Pacira sues FDA over pain drug marketing restrictions Reuters
Sep-02-15 07:00AM  Amarin to Present at the Rodman & Renshaw 2015 Global Investment Conference Marketwired +9.43%
Aug-28-15 05:15PM  3 Battleground Biotech Stocks I Would Avoid at All Costs at Motley Fool +6.70%
Aug-27-15 07:00AM  Amarin Announces Encore Presentation of Results of the Apolipoprotein C-III Post-Hoc Analysis From MARINE and ANCHOR Studies of Vascepa(R) at the European Society of Cardiology (ESC) 2015 Annual Congress Marketwired +10.00%
Aug-25-15 02:34PM  Nine Explanations For Why The FDA Is Approving Almost Every New Drug Application at Forbes
Aug-17-15 02:00PM  MTNB: Update on Second Quarter Financials
Aug-11-15 07:00AM  Amarin Promotes Joseph T. Kennedy to Executive Vice President, General Counsel and Strategic Initiatives Marketwired
Aug-10-15 03:21PM  Amarin (AMRN) Stock Loss Estimates Raised at Oppenheimer at TheStreet
08:17AM  Thalidomide, Drug Marketing And FDA Oversight at Forbes
Aug-07-15 10:08PM  Amarin Wins Off-Label Ruling Against FDA at The Wall Street Journal +14.22%
04:42PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events
04:22PM  Court sides against FDA in "off-label" drug promotion case
03:29PM  Why Amarin Corporation plc (ADR) is Moving Higher Today at Motley Fool
01:38PM  Judges Ruling Lets Drugmaker Promote Use Without FDA Approval at Bloomberg
12:57PM  [$$] Amarin Wins Off-Label Case Against FDA at The Wall Street Journal
10:49AM  First Amendment Decision a Win for Amarin and Physician Plaintiffs Marketwired
12:34AM  Edited Transcript of AMRN earnings conference call or presentation 6-Aug-15 8:30pm GMT
Aug-06-15 04:03PM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
04:01PM  Amarin Reports Second Quarter 2015 Financial Results and Provides Update on Operations Marketwired
07:07AM  Q2 2015 Amarin Corporation PLC Earnings Release - Time Not Supplied
Aug-05-15 04:27PM  Poseida Therapeutics, Inc., Expands Board of Directors GlobeNewswire -5.00%
04:15PM  Amarin to Host Second Quarter 2015 Earnings Conference Call and Webcast Live on Thursday, August 6, 2015 Accesswire
Jul-31-15 07:00AM  Amarin Announces Upcoming Presentations of Two Eicosapentaenoic Acid (EPA) Studies at the American Society for Preventive Cardiology (ASPC) Annual Cardiovascular Disease Prevention Conference and the Kern Lipid Conference Marketwired
Jul-30-15 07:00AM  Amarin to Report Second Quarter 2015 Results and Host Conference Call on August 6, 2015 Marketwired
Jul-11-15 10:03AM  3 Things You Should Know About Amarin Plc at Motley Fool
Jul-10-15 04:16PM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securi
09:35AM  5 Stocks Ready for Breakouts -- Must-See Charts at TheStreet
Jun-11-15 07:00AM  New In Vitro Eicosapentaenoic Acid Study Data to Be Presented at the National Lipid Association Scientific Sessions in Chicago Marketwired
Jun-08-15 07:00AM  New In Vitro Eicosapentaenoic Acid Study Data Presented June 6 at the American Diabetes Association Scientific Sessions in Boston Marketwired
Jun-03-15 03:40PM  Matinas and Amarin's Destinies are Linked as MAT9001 Outshines Vascepa Accesswire +5.65%
May-29-15 04:43PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events
08:37AM  Amarin (AMRN) in Focus: Stock Surges 19% in Session - Tale of the Tape
07:20AM  What Biotechnology Stocks Will Be Next To Enjoy The Bull Market? Accesswire
May-28-15 03:46PM  Amarin's Lawsuit Could Have Huge Benefits For Pharma Industry And Dire Consequences For Consumers at Forbes +18.97%
02:29PM  Amarin Granted Summary Judgment Motion in Suit Against FDA Seeking New Chemical Entity Market Exclusivity for Vascepa(R) (Icosapent Ethyl) Capsules Marketwired
02:26PM  U.S. court grants exclusivity for Amarin's Vascepa
May-26-15 05:00PM  Amarin to Present at the Jefferies 2015 Global Healthcare Conference Marketwired
May-18-15 08:31AM  Why Amarin Corporation (AMRN) Could Be Positioned for a Slump - Tale of the Tape
May-08-15 08:16AM  Secret Letter To Doctors Shows That The Amarin Lawsuit Is About Marketing, Not Free Speech at Forbes -6.57%
07:07AM  Q1 2015 Amarin Corporation PLC Earnings Release - Before Market Open
06:19AM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
06:00AM  Amarin Reports First Quarter 2015 Financial Results and Provides Update on Operations Marketwired
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product includes Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.